A Feasibility Study Evaluating the Use of SafeBreak Vascular in the Geriatric Trauma Population

Study participants will have a SafeBreak Vascular installed in each of their existing or newly installed IV lines. The clinical literature shows in prospective observational studies that a mean of 9.2% of patients dislodge their peripheral IVs. SafeBreak Vascular is a medical device designed to aid in the prevention of unintended disruption and dislodgement of IVs, such as peripheral IVs, peripherally inserted central lines, central lines, etc. SafeBreak IV will be installed in each IV line between the study participant's catheter and the IV tubing that goes to the IV bag or IV pump. When a harmful force is placed on the IV line, SafeBreak Vascular is designed to separate so that the harmful force is removed from the line and IV dislodgement is prevented. SafeBreak Vascular has a valve in each end of the device. Upon separation, each valves closes, stopping the flow of fluid. The primary objective of the study is to determine if the delivery of IV medications and/or fluids with SafeBreak Vascular functions with the same reliability as current standard IV tubing. The number of IV dislodgements and IV restarts will be recorded. The study will also collect data for analysis concerning the following:

• device design characteristics
• certain human factors (patient or operator) associated with the use of the device
• the impact of this device usage on clinician workflow
• any unknown safety concerns
• obtain preliminary data for use in designing a subsequent pivotal study of the device.

Inclusion criteria

• Geriatric trauma patients (> or equal to age 55)
• Participants able to provide informed consent or have a legally authorized representative (LAR) provide consent
• The patients must have IV access (existing central venous catheter, peripherally inserted central catheter, or peripheral IV's) or need IV access
• The patients must be at least 55 years of age.

Exclusion criteria

• Unable to obtain informed consent or without an available LAR to provide surrogate informed consent
• Age less than or equal to 54
• Patient on comfort care only
• Predicted to have less than 24 hours survival
• Patient enrolled in an investigational drug or device study at the time of enrollment
• Investigator discretion that patient is not suitable for the study